Test Price
2,800 AED✅ Home Collection Available
SATB2 Gene (Glass Syndrome) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
ISO 9001:2015 Certified
2800 AED
All-Inclusive
تحليل جين SATB2 لمتلازمة غلاس عبر تقنية التسلسل الجيني من الجيل التالي في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
📋 Executive Summary — الملخص التنفيذي
English — Clinical Assurance
- ✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO-Accredited NGS Processing, covering all coding exons, splice-site junctions, and clinically relevant intronic regions of the SATB2 gene (2q33.1).
- ✓ Premium Logistics: Paid Hospital-Grade Home Collection via ISO-Certified Cold-Chain Home Collection with VIP Mobile Phlebotomy available 8 AM – 11 PM across all seven Emirates.
- ✓ Clinical Guidance: Complimentary Telephonic Post-Test Clinical Guidance for result interpretation by a DHA-licensed clinical genetic counselor.
- ✓ Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731 — pre-authorization confirmed within 60 minutes during business hours.
العربية — الملخص التنفيذي السريري
- ✓ ضمان الدقة: حساسية تشخيصية بنسبة 99.9% عبر تقنية التسلسل الجيني من الجيل التالي (NGS) المعتمدة وفق معايير الآيزو، مع تغطية كاملة لجين SATB2.
- ✓ الخدمات اللوجستية: سحب منزلي معتمد بسلسلة تبريد معقمة وفق شهادة الآيزو، مع خدمة الفصد المخبري المتنقل لكبار الشخصيات من الساعة 8 صباحاً حتى 11 مساءً.
- ✓ الاستشارة السريرية: استشارة هاتفية مجانية بعد صدور النتائج لتفسير التقرير الجيني من قبل مستشار وراثي سريري مرخص من هيئة الصحة بدبي.
- ✓ التأمين: التحقق المباشر من تغطية التأمين الصحي عبر الواتساب — الموافقة المسبقة خلال 60 دقيقة.
🔍 Clinical Overview
The SATB2 Gene (Glass Syndrome) Genetic Test is a definitive molecular diagnostic assay that utilizes Next Generation Sequencing to analyze the entire coding region of the SATB2 gene located at chromosomal locus 2q33.1. Mutations in SATB2 are causative for Glass syndrome (SATB2-associated syndrome; SAS), a rare autosomal dominant neurodevelopmental disorder characterized by intellectual disability, severe speech impairment, craniofacial dysmorphism, dental anomalies, and cleft palate. يُعد هذا الفحص الجيني الشامل الأداة التشخيصية المرجعية لتأكيد متلازمة غلاس لدى الأطفال والبالغين الذين تظهر عليهم علامات سريرية متوافقة.
| Feature | ✅ Our NGS Test (ISO-Certified) | ⚠️ Closest Alternative (Sanger / CMA) |
|---|---|---|
| Methodology | Next Generation Sequencing (NGS) — Full gene coverage including exons, splice sites, and regulatory intronic regions | Targeted Sanger sequencing (limited to known hotspots) or Chromosomal Microarray (detects only large deletions >50 kb) |
| Diagnostic Precision | 99.9% Sensitivity — Detects SNVs, indels, and copy number variants (CNVs) in a unified workflow | ~70–85% Sensitivity — Misses deep intronic, regulatory, and mosaic variants; requires sequential reflex testing |
| Turnaround Time | 3 to 4 Weeks — ISO 9001:2015 accredited processing with dual-clinician variant interpretation | 6 to 12 Weeks — Fragmented workflow across multiple laboratories; higher rate of inconclusive reports |
| Clinical Utility | Comprehensive — Informs prognosis, recurrence risk counseling, and eligibility for emerging targeted therapies | Partial — May require additional testing; limited utility for familial variant segregation analysis |
🩺 Physician Insight & Clinical Safety Protocol
"As a clinician with decades of experience in pediatric genetics, I emphasize that the SATB2 NGS test result must always be interpreted in the context of a comprehensive clinical evaluation. A positive result confirms the molecular diagnosis and empowers families with clarity for recurrence risk counseling and early intervention planning. A negative result, however, does not exclude the diagnosis if clinical suspicion remains high — mosaic variants, promoter-region mutations, or epigenetic modifiers may warrant broader genomic investigation. I urge all families to seek structured genetic counseling before and after testing to fully understand the implications for their child's health trajectory."
— Dr. PRABHAKAR REDDY, DHA License: 61713011
Specialist in Clinical Genomics & Pediatric Dysmorphology
⚠️ Critical Medication Advisory
Do not discontinue any prescribed medication or alter your child's therapeutic regimen without consulting your treating physician. This genetic test is a diagnostic tool and does not replace ongoing clinical management. Results may take up to 4 weeks; continue all prescribed treatments, including anti-epileptics, speech therapy, and nutritional plans, during the testing period.
🚨 Patient Safety: Exclusion Criteria & Emergency Red Flags
Exclusion Criteria for Home Collection:
- Active febrile illness (temperature ≥ 38.5°C / 101.3°F)
- Known bleeding diathesis or platelet count < 50,000/µL without hematologist clearance
- Recent blood transfusion (< 14 days prior) — may cause donor DNA interference
- Current chemotherapy cycle — coordinate with oncologist for optimal collection window
- Neonates weighing < 2.5 kg — requires NICU-based phlebotomy, not home collection
Emergency Red Flags — Seek Immediate Medical Attention:
- New-onset seizures or status epilepticus in the patient
- Respiratory distress or cyanosis unresponsive to home oxygen
- Severe feeding difficulties with weight loss > 10% of body weight in one week
- Signs of increased intracranial pressure (persistent vomiting, lethargy, bulging fontanelle in infants)
- Acute behavioral regression with loss of previously acquired motor or language skills
Emergency Contact: Call 998 (UAE Ambulance) or visit your nearest emergency department immediately for any of the above red-flag symptoms. This genetic testing service does not provide emergency medical care.
❓ Patient FAQ & Clinical Guidance
Q1: What is the SATB2 Gene Glass Syndrome NGS Test and why is it clinically important for my child?
The SATB2 NGS test is a comprehensive genetic analysis that sequences the entire SATB2 gene to identify pathogenic mutations causing Glass syndrome, a rare autosomal dominant disorder characterized by intellectual disability, absent or severely impaired speech, distinctive craniofacial features, and dental anomalies. This test provides a definitive molecular diagnosis, enabling early intervention planning, accurate recurrence risk assessment for future pregnancies, and access to syndrome-specific multidisciplinary care pathways. Clinical diagnosis alone is often insufficient due to phenotypic overlap with other neurodevelopmental disorders such as Angelman syndrome, Pitt-Hopkins syndrome, and 2q33.1 microdeletion syndrome — making molecular confirmation through NGS the gold standard for precision diagnosis.
س1: ما هو تحليل جين SATB2 لمتلازمة غلاس وما أهميته السريرية لطفلي؟
تحليل جين SATB2 هو فحص جيني شامل يقرأ التسلسل الكامل لجين SATB2 للكشف عن الطفرات المرضية المسببة لمتلازمة غلاس، وهو اضطراب جيني نادر يتميز بالإعاقة الذهنية، وغياب أو ضعف شديد في النطق، وملامح وجهية مميزة، وتشوهات سنية. يوفر هذا الفحص تشخيصاً جزيئياً قاطعاً يتيح التخطيط المبكر للتدخلات العلاجية وتقييم خطر تكرار الحالة في الأحمال المستقبلية.
Q2: How is the sample collected for this test and what is the exact turnaround time in the UAE?
Sample collection is performed via a minimally invasive venous blood draw (3–5 mL in EDTA tube), or alternatively using a dried blood spot on an FTA card from a single finger-prick drop, with extracted DNA also accepted if previously banked. Our DHA-licensed mobile phlebotomy team provides hospital-grade home collection across all seven Emirates between 8 AM and 11 PM, utilizing ISO-certified cold-chain logistics to preserve DNA integrity during transport to our central laboratory. The standard turnaround time is 3 to 4 weeks from sample accessioning to final clinical report issuance. Expedited processing (2 weeks) is available upon request for urgent clinical scenarios, subject to additional fees and prior approval from our laboratory director.
س2: كيف يتم جمع العينة وما هي المدة الزمنية الدقيقة لصدور النتائج في الإمارات؟
يتم جمع العينة عبر سحب دم وريدي بسيط (3-5 مل في أنبوب EDTA)، أو بدلاً من ذلك باستخدام بطاقة FTA عبر قطرة دم واحدة من وخز الإصبع، كما تُقبل عينات الحمض النووي المستخلص المحفوظة مسبقاً. يقوم فريق الفصد المخبري المتنقل المرخص من هيئة الصحة بدبي بخدمة السحب المنزلي في جميع الإمارات السبع بين 8 صباحاً و11 مساءً، مع سلسلة تبريد معتمدة. المدة القياسية لصدور التقرير هي 3 إلى 4 أسابيع.
Q3: Does health insurance in the UAE cover the SATB2 Gene Glass Syndrome Genetic Test?
Most UAE-based comprehensive health insurance plans provide coverage for medically indicated genetic testing when accompanied by a referral letter from a DHA-licensed pediatrician, clinical geneticist, or neurologist documenting clinical suspicion of Glass syndrome based on established diagnostic criteria. Our dedicated insurance verification team processes direct billing approvals via WhatsApp at +971 54 548 8731 — simply send a photo of your insurance card and the physician's referral, and we will confirm coverage within 60 minutes during business hours. For plans with genetic testing exclusions or high deductibles, we offer transparent self-pay packages at 2800 AED with no hidden charges. Pre-authorization is mandatory under UAE PDPL regulations to ensure your genetic data privacy rights are fully protected throughout the billing process.
س3: هل يغطي التأمين الصحي في الإمارات العربية المتحدة تحليل جين SATB2 لمتلازمة غلاس؟
تغطي معظم خطط التأمين الصحي الشاملة في الإمارات الفحوصات الجينية ذات الدواعي الطبية عند تقديم خطاب إحالة من طبيب أطفال أو أخصائي وراثة سريرية مرخص من هيئة الصحة بدبي يوثق الاشتباه السريري بمتلازمة غلاس. يقوم فريق التحقق من التأمين لدينا بمعالجة الموافقات المباشرة عبر الواتساب — أرسل صورة بطاقة التأمين وخطاب الإحالة وسنؤكد التغطية خلال 60 دقيقة. للخطط التي تستثني الفحوصات الجينية، نوفر باقات دفع ذاتي شفافة بقيمة 2800 درهم.
📋 Pre-Test Requirements & Specimen Logistics
📝 Clinical Prerequisites
- Comprehensive clinical history of the patient, including developmental milestones, speech-language evaluation reports, and prior genetic testing results (if any)
- Detailed dysmorphology assessment notes from referring physician
- A genetic counseling session to draw a three-generation pedigree chart documenting all family members affected with or suspected of having SATB2-associated features
🧪 Accepted Specimen Types
- Whole Blood: 3–5 mL in K2-EDTA (lavender-top) tube — gold standard
- Extracted DNA: ≥ 2 µg at concentration ≥ 50 ng/µL, A260/A280 ratio 1.8–2.0
- Dried Blood Spot (FTA Card): One drop of whole blood applied to each indicated circle; air-dry completely at room temperature for ≥ 3 hours before packaging
🚚 Specimen Transport & Stability
- Whole Blood: Stable at 2–8°C for up to 7 days; do not freeze
- Extracted DNA: Ship on cold packs; stable at -20°C for long-term storage
- FTA Cards: Stable at ambient temperature (15–30°C) for up to 30 days; protect from humidity and direct sunlight
- ISO-Certified cold-chain courier provided for all home collections
⚠️ Pre-Collection Considerations
No specific dietary restrictions or fasting are required for DNA-based genetic testing. However, patients should inform the phlebotomist of all current medications and supplements, including over-the-counter products, as certain anticoagulants (e.g., warfarin, heparin, direct oral anticoagulants) may affect sample quality or prolong bleeding at the venipuncture site. For patients on anticoagulation therapy, coordinate collection timing with the treating physician. Do not discontinue any prescribed medication without explicit medical approval.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians